Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HPV16 L1 major capsid protein is essential for forming the protective shell around viral genetic material, mediating early steps in infection by binding to cell surface receptors, undergoing conformational changes necessary for entry/uncoating processes within host epithelial cells, stabilizing genomic material during trafficking/nuclear import—and serving as a primary antigenic target exploited by current highly effective prophylactic vaccines against oncogenic HPVs.
Vaccine-induced antibody neutralization of viral entry; Prevention of HPV infection and subsequent development of HPV-related diseases.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Type 16 L1 Major Capsid Protein (L1).